HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George W Woodfield Selected Research

Phenobarbital (Luminal)

3/2016EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
6/2014Sumoylation pathway is required to maintain the basal breast cancer subtype.
4/2014Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer.
4/2014Distinct pathways regulated by RET and estrogen receptor in luminal breast cancer demonstrate the biological basis for combination therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George W Woodfield Research Topics

Disease

10Breast Neoplasms (Breast Cancer)
03/2016 - 03/2007
4Neoplasms (Cancer)
03/2016 - 09/2007
3Carcinogenesis
03/2016 - 10/2010
1Triple Negative Breast Neoplasms
12/2015

Drug/Important Bio-Agent (IBA)

5Hormones (Hormone)IBA
03/2016 - 03/2007
5Estrogen Receptor alphaIBA
12/2015 - 03/2007
4Phenobarbital (Luminal)FDA Link
03/2016 - 04/2014
3Tyrosine Kinase InhibitorsIBA
03/2016 - 04/2014
3ChromatinIBA
03/2016 - 06/2009
3vandetanib (ZD6474)IBA
03/2016 - 04/2014
3Transcription Factors (Transcription Factor)IBA
06/2014 - 03/2007
3Estrogen ReceptorsIBA
04/2014 - 07/2013
2Sunitinib (Sutent)FDA Link
12/2015 - 04/2014
2Estrogen Receptor Modulators (Antiestrogen)IBA
04/2014 - 04/2014
1Therapeutic UsesIBA
03/2016
1ErbB Receptors (EGF Receptor)IBA
12/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
12/2015
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
12/2015
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2015
1Small Interfering RNA (siRNA)IBA
12/2015
1TamoxifenFDA LinkGeneric
04/2014
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
04/2014
1Mitogen-Activated Protein Kinase 3IBA
04/2014
1Biological ProductsIBA
04/2014
1Messenger RNA (mRNA)IBA
07/2013
1Proteins (Proteins, Gene)FDA Link
07/2013
1Histones (Histone)IBA
06/2009
1Insulin-Like Growth Factor Binding Protein 3IBA
09/2007
1Estrogens (Estrogen)FDA Link
09/2007
1Pharmaceutical PreparationsIBA
09/2007
1Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2007
1cellular retinoic acid binding protein IIIBA
03/2007

Therapy/Procedure

3Therapeutics
04/2014 - 09/2007